Archive for February, 2008
« Previous EntriesFriday’s Top Medical & Biotech Stocks
Friday, February 29th, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
MOMENTA PHARMA [MNTA] +28.61%
TRANSDEL PHARMACTL [TDLP.OB] +23.33%
CHAMPIONS BIOTECHNLG [CSBR.OB] +13.45%
CARDIUM THERAPEUTICS [CXM] +13.33%
ATHERSYS INC [ATHX] +11.25%
Diagnostic Substances
IMMUCELL CP [ICCC] +10.20%
PRESSURE BIOSCIENC [PBIO] +3.26%
SYNTA PHARMACEUTICAL [SNTA] +2.90%
ICAGEN, INC. [ICGN] +2.34%
TRINITY […]
Latest DTN Ethanol News
Friday, February 29th, 2008Submitted by DTN Ethanol Blog
Bernanke: Lower Brazil Ethanol Tariff
Federal Reserve Chairman Ben Bernanke said on Thursday he favored cutting high tariffs on Brazilian ethanol to help take pressure off food prices.
Higher Blends Key to Ethanol Future
Americans Don’t Know Ethanol
Dinneen: Ethanol Industry Sound
Focus on Fuels 2-25-08
Poet Funds Starch-to-Ethanol Research Collaboration
AE Biofuels Breaks Ground on Mont. Cellulosic […]
US healthcare spending nearly double by 2017
Friday, February 29th, 2008Submitted by THE HEALTH ECONOMICS BLOG
According to a recent article (see below), US healthcare spending will be skyrocking in the years to come. Given the difficulties in making coverage decions, I suppose managed care organizations will increasingly request solid economic value propositions of new products seeking formulary listing…
February 26, 2008
US healthcare spending to nearly double […]
Replidyne Announces Year-end Results
Friday, February 29th, 2008Submitted by BioHealth Investor Blog
by Adam Rubenstein
CLSDF
IMHO I remain incredibly optimistic about Replidyne’s (NASDAQ: RDYN), a leader in next-generation anti-infective products, direction (note: this in no why should be interpreted as investment advice). After being dealt a bum deal by the FDA re: a change in protocol for antibiotic trials, management at Replidyne has retrenched. […]
Thursday’s Top Medical & Biotech Stocks
Friday, February 29th, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
TRANSDEL PHARMACTL [TDLP.OB] +25.00%
OCTILLION CORP NEW [OCTL.OB] +21.09%
EXACT SCIENCES COR [EXAS] +20.32%
BARRIER THERAPEUTICS [BTRX] +9.88%
GPC BIOTECH AG [GPCB] +8.87%
Diagnostic Substances
HUMAN GENOME SCI [HGSI] +8.85%
IMMUNOMEDICS INC [IMMU] +4.18%
SCOLR PHARMA INC […]
AstraZeneca - Seroquel: stop this madness
Friday, February 29th, 2008Submitted by PharmaGossip Blog
Ed has the story.
And here’s why it’s not a good idea.
Sphere: Related Content
It’s TED time
Friday, February 29th, 2008Submitted by PharmaGossip Blog
This week, TED2008 and TED@Aspen are asking The Big Questions: Who are we? What is our place in the universe? Is beauty truth? You can follow the conferencevirtually via the TED Blog and our many live-bloggers (see the TED Blog for the ever-growing list) — and via a very special event on […]
Roche - Mircera: time to think things over
Friday, February 29th, 2008Submitted by PharmaGossip Blog
A federal judge in Massachusetts has tentatively barred Roche Holding from selling its anemia drug in the United States after a jury found it violated an Amgen Inc. patent.
But U.S. District Judge William Young said Thursday he is open to allowing sales of the drug Mircera if Roche agrees to certain conditions.
Those […]
Jarvik - The Playboy Interview
Friday, February 29th, 2008Submitted by PharmaGossip Blog
From Playboy magazine, April 1986:
The rock ‘n’ roll heart of Robert Jarvik; creator of artificial heart
By Laurence Gonzales
The heart in his hand clicks with scientific precision…
Strange as my circumstances were, the terms of this debate are as old and commonplace as man.
On good days, he seemed normal enough. About eight in the […]
Shhhh!
Thursday, February 28th, 2008Submitted by PharmaGossip Blog
Quack
Sphere: Related Content
Volunteers?
Thursday, February 28th, 2008Submitted by PharmaGossip Blog
Click on image for larger.
Sphere: Related Content
AstraZeneca - Recentin: uh oh, a wheel falls off
Thursday, February 28th, 2008Submitted by PharmaGossip Blog
AstraZeneca is stopping a clinical trial of Recentin as a treatment for lung cancer after a mid-stage study failed to meet its main goal, although trials in colorectal cancer will move ahead.
The mixed news on Wednesday adds to the company’s patchy record on drug research at a time when its two top […]
Novartis’ pipeline premium is drying up
Thursday, February 28th, 2008Submitted by PharmaGossip Blog
A premium on Swiss drugmakerNovartis AG’s stock is under threat as a thin portfolio of new drugs provides scant confidence in its hopes for a second-half recovery.
Novartis shares lost 12 percent of their value in 2007, knocked by delays to key products and the withdrawal of bowel drug Zelnorm from U.S. shelves, […]
Negative trials, aint they a bitch?
Thursday, February 28th, 2008Submitted by PharmaGossip Blog
An election pledge to require drugs companies to publish full details of clinical trials for medicines cannot be fulfilled because it is illegal under EU law, the UK Government has admitted.
Psychiatrists and health campaigners renewed a call yesterday for all data on the effectiveness of medicines to be published after a review […]
20 Surprising Ways Wal-Mart Clinics Will Affect US Healthcare
Thursday, February 28th, 2008Submitted by BioHealth Investor Blog
By Jessica Hupp
RNCentral
Big-box behemoth Wal-Mart has ventured into the healthcare realm, offering low-cost, walk-in clinics in more and more of its stores every day. Although Wal-Mart medicine may not sound like a great idea at first, these clinics can bring good changes to the health care industry, like insurance-free care, eased […]
Wednesday’s Top Medical & Biotech Stocks
Thursday, February 28th, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
VION PHARM INC [VIOND] +17.33%
SEQUENOM INC [SQNM] +9.14%
CORCEPT THERAPEUTICS [CORT] +7.91%
MEDAREX INC [MEDX] +7.48%
IMMUNOSYN CORPORATIN [IMYN.OB] +5.61%
Diagnostic Substances
IMMUNOMEDICS INC [IMMU] +5.29%
AVIGEN INC [AVGN] +5.12%
MONOGRAM BIOSCIENCES [MGRM] +3.42%
TORREYPINES THERAPEU [TPTX] […]
Truth and Big Pharma - The Back Triangle speaks
Wednesday, February 27th, 2008Submitted by PharmaGossip Blog
Anthony Cox writes:
Even accepting Ben Goldacre’s points about poor media reporting tagged on the end of his excellent post about the pharmaceutical industry’s failures to give the whole story about their products, prompted by the PLOS study on anti-depressants, it has to be accepted that the Independent’s front page lead screaming Drug […]
Boom!
Wednesday, February 27th, 2008Submitted by PharmaGossip Blog
.
Sphere: Related Content
Andy’s team!
Wednesday, February 27th, 2008Submitted by PharmaGossip Blog
Ed dissects the Commish!
Sphere: Related Content
RX - sex and drugs and quarterly goals - Part 4
Wednesday, February 27th, 2008Submitted by PharmaGossip Blog
Pharmaceuticals is an ugly business. But thank God the reps are hot. Created by Paul L. Mays and Torrance Hill .
Catch up with the series
Part 1: http://revver.com/video/655108
Part 2: http://revver.com/watch/682048
Part 3: http://revver.com/watch/694069
And now:
Part 4: http://revver.com/watch/694073
“GET ADDICTED”
Sphere: Related Content
Welcome to the eDrugSearch.com Community
Wednesday, February 27th, 2008Submitted by PharmaGossip Blog
SAN ANTONIO – Feb. 27, 2008 – eDrugSearch.com, the trusted search engine for Americans seeking medications from prescreened international pharmacies, has expanded its mission by unveiling the eDrugSearch.com Community, a new social network for prescription drug consumers.
“U.S. consumers who want access to prescription drugs at fair, affordable prices have long had the […]
The Father, Son and
Wednesday, February 27th, 2008Submitted by PharmaGossip Blog
Holy Toast
Sphere: Related Content
PR - economical with the actualité?
Wednesday, February 27th, 2008Submitted by PharmaGossip Blog
Gawker.com, the media gossip blog, recently had a testy exchange with Richard Edelman, CEO of the giant Edelman public relations firm, after Gawker published an item which quoted an unnamed Edelman employee who reportedly advised a client, “Sometimes, you just have to stand up there and lie. Make the audience or the […]
Say Hi to Allison - drug rep, former gambling addict and Big Brother contestant
Wednesday, February 27th, 2008Submitted by PharmaGossip Blog
Allison attended Rollins College in Winter Park, Florida and graduated with a bachelor of arts/psychology degree in 2002. She also spent a semester at sea, world travel, in the spring of that year.
She currently works in pharmaceutical sales where she works with specialists in the pulmonology/allergy sector.
She is also part owner […]
Safety First!
Wednesday, February 27th, 2008Submitted by PharmaGossip Blog
WSJ
Sphere: Related Content
